Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease

被引：0

作者：

Waldron, Evan ^{[1
]}

Tanhehco, Yvette C. ^{[1
,2
]}

机构：

[1] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, 622W 168th St, New York, NY 10032 USA

[2] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, Div Transfus Med, 622W 168th St Harkness Pavil,4-418A, New York, NY 10032 USA

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2022年 / 61卷 / 05期

关键词：

Hematopoietic stem cell transplantation; Gene therapy; Sickle cell disease; CRISPR-Cas9; Lentiglobin; RNA interference; DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; COMPLEX; GENOME; HEMOGLOBIN; ALLOIMMUNIZATION; INTERFERENCE; DETERMINANTS; LENTIVIRUS; EXPRESSION;

D O I：

10.1016/j.transci.2022.103566

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gene therapy will soon become the dominant modality for treating of sickle cell disease (SCD). Currently, three technologies are the most promising: expression of transgenic globin genes via a lentiviral vector, controlled mutation of the 8-globin control cluster by transgenic CRISPR-based ribonucleoprotein, and suppression of BCL11a mRNA by shRNA. In this review, we discuss the mechanism of each technology and how they correct the SCD pathology at the molecular level. We conclude by discussing potential directions future therapy may take.

引用

页数：6

共 50 条

[31] Editorial: Developments in sickle cell disease therapy and potentials for gene therapy
Maitta, Robert W.
Reeves, Hollie M.
Fontaine, Magali J.
FRONTIERS IN MEDICINE, 2023, 10
[32] Progress toward safe and effective gene therapy for β-thalassemia and sickle cell disease
Lebensburger, Jeffrey
Persons, Derek A.
CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (02) : 225 - 232
[33] Treatment Options for Sickle Cell Disease
Meier, Emily Riehm
PEDIATRIC CLINICS OF NORTH AMERICA, 2018, 65 (03) : 427 - +
[34] Voxelotor for the treatment of sickle cell disease
Vissa, Madhav
Vichinsky, Elliott
EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (03) : 253 - 261
[35] Application of Molecular Biology Studies to Gene Therapy Treatment Strategies
Allen Gustin
Lee Pederson
Ryan Miller
Carlos Chan
Selwyn M. Vickers
World Journal of Surgery, 2002, 26 : 854 - 860
[36] CRISPR/Cas9-based gene-editing technology for sickle cell disease
Ma, Liangliang
Yang, Shanglun
Peng, Qianya
Zhang, Jingping
Zhang, Jing
GENE, 2023, 874
[37] Transfusion Therapy in Children With Sickle Cell Disease
Inati, Adlette
Mansour, Anthony G.
Sabbouh, Toni
Amhez, Ghid
Hachem, Ahmad
Abbas, Hussein A.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (02) : 126 - 132
[38] Financial Impacts of Paying for Gene Therapy for Sickle Cell Disease Under Alternative Pricing and Financing Mechanisms
Basu, Anirban
VALUE IN HEALTH, 2025, 28 (02) : 233 - 240
[39] Globin gene transfer for treatment of the β-thalassemias and sickle cell disease
Sadelain, M
Rivella, S
Lisowski, L
Samakoglu, S
Rivière, I
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (03) : 517 - 534
[40] Understanding Sickle cell disease: Causes, symptoms, and treatment options
Elendu, Chukwuka
Amaechi, Dependable C.
Alakwe-Ojimba, Chisom E.
Elendu, Tochi C.
Elendu, Rhoda C.
Ayabazu, Chiagozie P.
Aina, Titilayo O.
Aborisade, Ooreofe
Adenikinju, Joseph S.
MEDICINE, 2023, 102 (38) : E35237

← 1 2 3 4 5 →